These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10178468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL.
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [Abstract] [Full Text] [Related]

  • 3. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC, Okpara IR, Agnese WB, Toscani M.
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [Abstract] [Full Text] [Related]

  • 4. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK, Sause RB, Zacker C.
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacoeconomic analysis in formulary decisions: an international perspective.
    Johnson JA, Bootman JL.
    Am J Hosp Pharm; 1994 Oct 15; 51(20):2593-8. PubMed ID: 7847423
    [Abstract] [Full Text] [Related]

  • 7. The case for a value-based formulary: striving for total lowest net cost.
    Weart W, Bauman GR.
    Manag Care Interface; 2007 Apr 15; 20(4):42-7. PubMed ID: 17474330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
    Earnshaw SR, Wilson MR, Dalal AA, Chambers MG, Jhingran P, Stanford R, Mapel DW.
    Respir Med; 2009 Jan 15; 103(1):12-21. PubMed ID: 19010652
    [Abstract] [Full Text] [Related]

  • 10. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
    Wang SW, Liu X, Wiener DJ, Sennett C, Bowers BW, Legorreta AP.
    Am J Manag Care; 2001 Sep 15; 7(9):913-22. PubMed ID: 11570024
    [Abstract] [Full Text] [Related]

  • 11. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
    Sullivan SD, Lee TA, Blough DK, Finkelstein JA, Lozano P, Inui TS, Fuhlbrigge AL, Carey VJ, Wagner E, Weiss KB.
    Arch Pediatr Adolesc Med; 2005 May 15; 159(5):428-34. PubMed ID: 15867115
    [Abstract] [Full Text] [Related]

  • 12. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G.
    J Clin Psychiatry; 2003 May 15; 64 Suppl 17():29-32. PubMed ID: 14680425
    [Abstract] [Full Text] [Related]

  • 13. The use of pharmacoeconomic data in managed care: closing the credibility gap.
    Lewis BE.
    Manag Care Interface; 1997 Nov 15; 10(11):99-103. PubMed ID: 10174761
    [Abstract] [Full Text] [Related]

  • 14. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb 15; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 15. Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment.
    Sheehan DV, Wright-Etter PJ.
    Manag Care Q; 2002 Feb 15; 10(3):21-31. PubMed ID: 12476662
    [Abstract] [Full Text] [Related]

  • 16. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB, Sullivan SD, Augenstein D, Fullerton DS, Atherly D.
    Am J Manag Care; 1999 Mar 15; 5(3):277-85. PubMed ID: 10351024
    [Abstract] [Full Text] [Related]

  • 17. Effects of an asthma management program on the asthmatic member: patient-centered results of a 2-year study in a managed care organization.
    Buchner DA, Butt LT, De Stefano A, Edgren B, Suarez A, Evans RM.
    Am J Manag Care; 1998 Sep 15; 4(9):1288-97. PubMed ID: 10185979
    [Abstract] [Full Text] [Related]

  • 18. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA, Barghout V, Kahler KH, Bentkover J, Kurth H, Gralnek IM, Spiegel BM.
    Am J Manag Care; 2005 Apr 15; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [Abstract] [Full Text] [Related]

  • 19. Looking beyond the formulary budget in cost-benefit analysis.
    Cohen LJ.
    Am J Manag Care; 1997 Feb 15; 3 Suppl():S11-7. PubMed ID: 10180337
    [Abstract] [Full Text] [Related]

  • 20. Formulary: what it is and how it works.
    Smith G.
    J Healthc Resour Manag; 1996 Sep 15; 14(7):11-3. PubMed ID: 10161584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.